Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ark (Absolute Return for Kids) is an international children's charity and non-profit organization founded in 2002 by a group of prominent UK hedge fund managers, including Arpad Busson and Ian Wace. The organization operates on a venture philanthropy model, applying business discipline and rigorous metrics to social interventions in education, health, and child protection. In the healthcare sector, Ark has historically managed significant programs to combat HIV/AIDS in South Africa and Mozambique, as well as large-scale rotavirus and typhoid vaccination initiatives in Zambia and Zimbabwe. While its current primary focus is the management of its network of academy schools in the United Kingdom, Ark continues to support global health systems through strategic partnerships with organizations like Gavi, the Vaccine Alliance. The organization is well-regarded for its ability to scale effective interventions and transition them to government management for long-term sustainability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Absolute Return for Kids.